What is NDC 51672-1373?

51672-1373 is the product NDC for Tazarotene, Tazarotene 1 mg/g cream, listed with the FDA by Sun Pharmaceutical Industries, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Sun Pharmaceutical Industries, Inc., NDC labeler code 51672. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tazarotene?

14 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tazarotene NDC 51672-1373 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51672-1373Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51672-1373Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51672-1373-2	5167213730251672137302	1 TUBE in 1 CARTON (51672-1373-2) / 30 g in 1 TUBEMarketed from Apr 3, 2017
51672-1373-3	5167213730351672137303	1 TUBE in 1 CARTON (51672-1373-3) / 60 g in 1 TUBEMarketed from Apr 3, 2017

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tazarotene
Generic name (nonproprietary): tazarotene
Active ingredients: Tazarotene — 1 mg/g
Dosage form: Cream
Route: Topical
Labeler: Sun Pharmaceutical Industries, Inc.NDC labeler code 51672
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208258
Marketing start: Apr 3, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 51672-1373_4653c9f0-dc97-b1e2-e063-6294a90aaf8bSPL ID 4653c9f0-dc97-b1e2-e063-6294a90aaf8bSPL set ID 478ff059-9d7b-438e-a64e-c853dfac2872RxCUI 313200UNII 81BDR9Y8PSUPC 0351672137328
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451672137302 followed by a unit qualifier and the quantity

Package 51672-1373-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 19, 2025.

Indications (excerpt from the label)

Tazarotene cream 0.1% is a retinoid indicated for the topical treatment of plaque psoriasis. ( 1.1 ) Tazarotene cream 0.1% is indicated for the topical treatment of acne vulgaris. ( 1.2 ) 1.1 Plaque Psoriasis Tazarotene cream, 0.1% is indicated for the topical treatment of patients with plaque psoriasis. 1.2 Acne Vulgaris Tazarotene cream, 0.1% is also indicated for the topical treatment of patients with acne vulgaris.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51672-1373

What is NDC 51672-1373?: 51672-1373 is the product NDC for Tazarotene, Tazarotene 1 mg/g cream, listed with the FDA by Sun Pharmaceutical Industries, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tazarotene.
What is the active ingredient?: Tazarotene.
Who is the labeler?: Sun Pharmaceutical Industries, Inc., NDC labeler code 51672. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tazarotene?: 14 other product NDCs are listed under this name. See all Tazarotene NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tazarotene NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tazarotene	Tazarotene .5 mg/g	CreamTopical	Cosette Pharmaceuticals, Inc.	0713-0765	00713-0765-3100713-0765-60
Tazarotene	Tazarotene .5 mg/g	GelCutaneous	Solaris Pharma Corporation	73473-309	73473-0309-1073473-0309-30
Tazarotene	Tazarotene 1 mg/g	GelCutaneous	Solaris Pharma Corporation	73473-310	73473-0310-1073473-0310-30
Tazarotene	Tazarotene .5 mg/g	CreamTopical	Padagis Israel Pharmaceuticals Ltd	45802-706	45802-0706-9445802-0706-96
Tazarotene	Tazarotene .5 mg/g	CreamTopical	Bryant Ranch Prepack	72162-2420	72162-2420-0372162-2420-06
Tazarotene	Tazarotene .5 mg/g	GelTopical	Padagis Israel Pharmaceuticals Ltd	45802-436	45802-0436-0145802-0436-94
Tazarotene	Tazarotene 1 mg/g	GelTopical	Padagis Israel Pharmaceuticals Ltd	45802-442	45802-0442-0145802-0442-94
Tazarotene	Tazarotene 1 mg/g	GelTopical	Bryant Ranch Prepack	72162-2202	72162-2202-03
Tazarotene	Tazarotene 1 mg/g	GelTopical	Cosette Pharmaceuticals, Inc.	0713-0804	00713-0804-3100713-0804-99
Tazarotene	Tazarotene .5 mg/g	GelTopical	Cosette Pharmaceuticals, Inc.	0713-0805	00713-0805-3100713-0805-99

All 15 Tazarotene NDCs

Other NDCs under ANDA 208258

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208258
Product	Strength	Form · route	Labeler	Product NDC
Tazarotene	Tazarotene 1 mg/g	CreamTopical	Sun Pharmaceutical Industries, Inc.	51672-1374